Qian-Qian chen | Pharmacology | Best Researcher Award

Posted on by Pencis

Prof. Qian-Qian chen | Pharmacology | Best Researcher Award 

Prof. Qian-Qian chen, Nanjing University of Chinese Medicine, China

Prof. Qian-Qian Chen is an Associate Professor at the School of Pharmacy at Nanjing University of Chinese Medicine, China. He holds a Ph.D. in Pharmacognosy from China Pharmaceutical University, Nanjing. His research focuses on the molecular mechanisms of cardiovascular and renal diseases, the regulatory effects of traditional Chinese medicine (TCM) on disease progression, and the role of the neuraminidase protein family in chronic conditions. Prof. Chen has published extensively in high-impact journals such as Advanced Science, Nature Communications, and European Heart Journal. He is committed to advancing both modern pharmacology and TCM in the context of chronic diseases.

Author Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Qian-Qian Chen began his academic journey with a Bachelor of Science in Pharmacy from Beihua University, Jilin, China, graduating in June 2015. Demonstrating exceptional academic potential, he pursued a Master’s degree in Pharmacy at China Pharmaceutical University, Nanjing, China, from September 2015 to July 2018. He further refined his expertise by completing a Ph.D. in Pharmacognosy at the same university, achieving his doctorate in July 2021.

🏫PROFESSIONAL ENDEAVORS:

Currently serving as an Associate Professor and Master’s Supervisor in Pharmacology at the School of Pharmacy, Nanjing University of Chinese Medicine, Prof. Chen has been in this role since March 2022. His teaching and mentorship significantly contribute to nurturing the next generation of researchers in pharmacology and traditional Chinese medicine (TCM).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Pharmacology:

Prof. Chen’s research is primarily centered around the molecular mechanisms underlying cardiovascular and renal diseases. His work focuses on three major areas:
1️⃣ Exploring the molecular pathways involved in cardiovascular and renal disease progression.
2️⃣ Investigating the regulatory effects of traditional Chinese medicine (TCM) on these diseases.
3️⃣ Unveiling the roles and mechanisms of the neuraminidase protein family in chronic conditions, including ventricular remodeling and chronic kidney injury.

His dedication to these fields has yielded a wealth of insights that advance understanding and treatment strategies for complex cardiorenal syndromes.

📈IMPACT AND INFLUENCE:

Prof. Chen has made significant contributions to the scientific community through his publications in prestigious journals. These include:

  • Advanced Science (2024)
  • Nature Communications (2023)
  • European Heart Journal (2021)
  • Journal of Ethnopharmacology (2021)
  • The American Journal of Chinese Medicine (2021)
  • Circulation (2018)

His groundbreaking studies on cardiovascular and renal diseases have been highly cited and praised for their clinical relevance and innovative methodologies.

📚ACADEMIC CITES AND LEGACY: 

Prof. Chen’s published work has been widely referenced in the fields of pharmacology, traditional Chinese medicine, and chronic disease research. His studies, particularly those addressing the interplay between cardiovascular and renal systems, serve as a cornerstone for researchers exploring related domains.

🌟FUTURE CONTRIBUTIONS AND VISION:

Looking ahead, Prof. Chen aims to:

  • Expand the understanding of traditional Chinese medicine’s regulatory roles in disease mechanisms.
  • Advance therapeutic strategies for chronic diseases through interdisciplinary research.
  • Mentor emerging researchers, fostering innovation and excellence in pharmacological sciences.

His commitment to merging modern scientific techniques with traditional medicine holds the promise of revolutionary breakthroughs in healthcare.

🌍CONCLUSION:

Prof. Qian-Qian Chen’s impressive academic trajectory, impactful research, and dedication to advancing pharmacology place him as a leading figure in his field. His work not only bridges the gap between traditional and modern medicine but also sets a foundation for transformative discoveries that will benefit patients worldwide.

Top Notable Publications:

Targeting Neuraminidase 4 Attenuates Kidney Fibrosis in Mice

Authors: Qian-Qian Chen

Journal: Advanced Science

Year: 2024

DOI: 10.1002/advs.202406936

Neuraminidase 1 is a Driver of Experimental Cardiac Hypertrophy

Authors: Qian-Qian Chen

Journal: European Heart Journal

Year: 2021

DOI: 10.1093/eurheartj/ehab347

Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases

Authors: Qian-Qian Chen

Journal: The American Journal of Chinese Medicine

Year: 2021

DOI: 10.1142/s0192415x21500403

PMID: 33827385

Untargeted Metabolomics and Lipidomics Uncovering the Cardioprotective Effects of Huanglian Jiedu Decoction on Pathological Cardiac Hypertrophy and Remodeling

Authors: Qian-Qian Chen

Journal: Journal of Ethnopharmacology

Year: 2020

DOI: 10.1016/j.jep.2020.113646

PMID: 33264659

Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

Authors: Qian-Qian Chen

Journal: Circulation

Year: 2017

DOI: 10.1161/circulationaha.117.031139

PMID: 29212895

Lakshmanan Loganathan | Pharmacogenomics | Best Researcher Award

Posted on by Pencis

Dr. Lakshmanan Loganathan | Pharmacogenomics | Best Researcher Award 

Dr. Lakshmanan Loganathan, Micro Health Laboratories, India

Dr. Lakshmanan Loganathan is a Scientist ‘C’ and Scientific Coordinator at Micro Health Laboratories, India, with over nine years of research experience and three years in the diagnostics field. Specializing in computational biology, drug design, microbial genomics, medical genetics, and pharmacogenomics, he has successfully led numerous research projects and developed innovative methodologies. Dr. Loganathan has expertise in structure-based and ligand-based drug design, molecular dynamics, RT-PCR, and SNP studies. With a strong background in computational skills, project management, and scientific communication, he is dedicated to advancing human health through cutting-edge research.

Profile:

Scopus Profile 

Orcid Profile

Google Scholar

 

Education Qualification:

 

Dr. Lakshmanan Loganathan holds a Ph.D. in Bioinformatics from Alagappa University, Karaikudi (2022), where he conducted a highly commendable thesis on RAS and CYP gene polymorphisms in anti-hypertensive treatment. He also earned a PG Diploma in Structural Pharmacogenomics (2015) with the university’s top rank and an M.Sc. in Bioinformatics (2014), both from Alagappa University, achieving high commendations for his innovative research in molecular docking and genomics. Additionally, he holds a B.Sc. in Microbiology from Yadava Arts & Science, Madurai (2012).

Professional Experiences:

Dr. Lakshmanan Loganathan is a Scientist ‘C’ and Scientific Coordinator at Micro Health Laboratories in India, where he has been instrumental in designing and implementing innovative experiments to develop cost-effective diagnostic tests since November 2022. His career includes extensive experience as a Research Scholar at Alagappa University, where he published multiple academic papers and contributed to collaborative research projects. Previously, he held positions such as Lab Manager and Research Associate at Rainbow Children’s Medicare, where he assisted in developing a molecular genetics laboratory and managed the NABL accreditation process. His role as Manager of Lab Operations at SciGene Diagnostics involved overseeing various departments and establishing effective communication with key stakeholders. With a strong background in research, diagnostics, and technical documentation, Dr. Loganathan is dedicated to advancing medical science through innovative methodologies and quality assurance processes.

 Academic Merit & Awards :

Dr. Lakshmanan Loganathan has made significant contributions to the field of bioinformatics, receiving numerous accolades throughout his academic and professional journey. He participated in the UGC-Resource Networking Summer Training Program at Jawaharlal Nehru University in 2013 and was honored with a certificate of appreciation from the Prime Minister of India for his involvement in the Republic Day Parade in 2014. In recognition of his outstanding academic performance during his M.Sc. at Alagappa University, he was named the “Meritorious Student of the Year” for 2013 and received several scholarships, including the PMT & VOC merit scholarship. During his Ph.D. tenure from 2015 to 2020, he was awarded fellowships from DBT, MHRD, and RUSA. Dr. Loganathan also received the special prize for best poster presentation at the ICCIPS-2019 conference and was recognized as the “INTERNATIONAL BEST RESEARCHER” in bioinformatics at the IISTAC-2022 congress.

Thesis work:

Dr. Lakshmanan Loganathan has a robust academic background in bioinformatics, with a focus on microbiology and pharmacogenomics. He completed a six-month post-M.Sc. dissertation on “Identification of Vibrio harveyi through 16s rRNA sequencing” under the guidance of Dr. P. Srinivasan at Alagappa University. Additionally, he undertook a six-month postgraduate diploma project on “Identification of potent inhibitors against NS3 helicase protein of Zika virus,” supervised by Dr. M. Karthikeyan. Dr. Loganathan’s Ph.D. thesis, titled “Role of RAS and CYP Gene Polymorphisms in Anti-Hypertensive Treatment,” also under the supervision of Dr. Karthikeyan, was highly commended for its contributions to pharmacogenomics and computational studies.

Top Notable Publications:

Renin and CYP P450 gene variations significantly associated with essential hypertension: A prospective pharmacogenomics study

Authors: Loganathan, L., Carlus, S.J., Muthusamy, K.

Year: 2024

Journal: Gene Reports

Volume: 37

Article Number: 102023

Citations: 0

HTNpedia: A Knowledge Base for Hypertension Research

Authors: Loganathan, L., Jeyaraman, J., Muthusamy, K.

Year: 2024

Journal: Combinatorial Chemistry and High Throughput Screening

Volume: 27(5)

Pages: 745–753

Citations: 0

In silico prediction, molecular modeling, and dynamics studies on the targeted next-generation sequencing identified genes underlying congenital heart disease in Down syndrome patients

Authors: Carlus, F.H., Sujatha, L.B., Kumar, A.G., Muthusamy, K., Carlus, S.J., et al.

Year: 2023

Journal: Annals of Pediatric Cardiology

Volume: 16(4)

Pages: 266–275

Citations: 0

Theoretical investigation on known renin inhibitors and generation of ligand-based pharmacophore models for hypertension treatment

Authors: Loganathan, L., Sankar, J., Rajendran, K., Muthusamy, K.

Year: 2023

Journal: Journal of Biomolecular Structure and Dynamics

Citations: 1

Targeting renin receptor for the inhibition of renin angiotensin aldosterone system: An alternative approach through in silico drug discovery

Authors: Loganathan, L., Briget Kuriakose, B., Lobelle Sampayan, E., Muthusamy, K.

Year: 2022

Journal: Computational and Theoretical Chemistry

Volume: 1208

Article Number: 113541

Citations: 1

An in silico analysis of the impact of POLE mutations on cladribine docking

Authors: Loganathan, L., Al-Haidose, A., Ganesh Kumar, A., Carlus, S.J., Abdallah, A.M.

Year: 2022

Journal: European Review for Medical and Pharmacological Sciences

Volume: 26(20)

Pages: 7580–7593

Citations: 3

Mechanistic insights on nsSNPs on binding site of renin and cytochrome P450 proteins: A computational perceptual study for pharmacogenomics evaluation

Authors: Loganathan, L., Kuriakose, B.B., Mushfiq, S., Muthusamy, K.

Year: 2021

Journal: Journal of Cellular Biochemistry

Volume: 122(10)

Pages: 1460–1474

Citations: 17

In silico drug designing for the identification of promising antagonist hit molecules against bradykinin receptor

Authors: Selvaraj, M., Loganathan, L., Kumar Thirumalaisamy, P., Lobelle Sampayan, E., Muthusamy, K.

Year: 2021

Journal: Computational and Theoretical Chemistry

Volume: 1202

Article Number: 113334

Citations: 0

Virtual screening assisted discovery of novel natural products to inhibit the catalytic mechanism of Mycobacterium tuberculosis InhA

Authors: Jayaraman, M., Loganathan, L., Muthusamy, K., Ramadas, K.

Year: 2021

Journal: Journal of Molecular Liquids

Volume: 335

Article Number: 116204

Citations: 21

Computational study on cross-talking cancer signalling mechanism of ring finger protein 146, AXIN and Tankyrase protein complex

Authors: Loganathan, L., Natarajan, K., Muthusamy, K.

Year: 2020

Journal: Journal of Biomolecular Structure and Dynamics

Volume: 38(17)

Pages: 5173–5185

Citations: 7